Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study

  • Published : 2013.01.02
⟨ Previous Next ⟩

Abstract

Background: D-dimer is used widely as a diagnostic aid in low- and moderate-risk patients with suspected venous thromboembolism (VTE). While our laboratory utilizes VIDAS D-dimer analyzer (bioM$\acute{e}$rieux SA, France), our emergency department (ED) recently procured a D-dimer analyzer AQT90 FLEX (Radiometer Medical ApS, Denmark) for point of care testing (POCT) to facilitate patient management. We aimed to determine whether the time taken to receive D-dimer results using the 2 different analyzers differed significantly and to quantify the limits of agreement between the results of the 2 methods measured on the same patient. Methods: Adult patients presenting to the ED and requiring diagnostic workup for suspected VTE were included in this prospective observational study. Patients underwent simultaneous D-dimer measurements using the 2 different analyzers. Results: The paired results from 104 patients were analyzed. The median time for the Ddimer results from triage by VIDAS was 258 min (Inter-quartile range [IQR], 173-360) and by POCT was 146 min (IQR, 55-280.5); the median time difference was 101.5 min (IQR, 82- 125.5). On an average, POCT D-dimer values were 15% lower on the same sample (limits of agreement, 34-213%). POCT predicted 83% of VIDAS positive results (sensitivity, 83.3% [95% confidence interval (CI), 70.4-91.3%]; specificity, 100% [95% CI, 93.6-100%]). All patients with positive imaging were identified correctly by both methods. Conclusions: POCT delivers D-dimer results in significantly shorter turnaround times than pathology services; however, poor bioequivalence between VIDAS and POCT raises the issue of acceptability for use in the ED.

Keywords

References

  1. Lee-Lewandrowski E, Nichols J, Van Cott E, Grisson R, Louissaint A, Benzer T, et al. Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization. Am J Clin Pathol 2009;132:326-31. https://doi.org/10.1309/AJCP6US3ILGEAREE
  2. Walker JB and Nesheim ME. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J Biol Chem 1999;274: 5201-12. https://doi.org/10.1074/jbc.274.8.5201
  3. Greenberg CS, Devine DV, McCrae KM. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Am J Clin Pathol 1987;87:94-100.
  4. Dempfle CE. Validation, calibration, and specificity of quantitative D-dimer assays. Semin Vasc Med 2005;5:315-20. https://doi.org/10.1055/s-2005-922476
  5. Pittet JL, de Moerloose P, Reber G, Durand C, Villard C, Piga N, et al. VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma. Clin Chem 1996;42:410-5.
  6. Scarano L, Bernardi E, Prandoni P, Sardella C, Rossi L, Carraro P, et al. Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. Thromb Res 1997;86:93-9. https://doi.org/10.1016/S0049-3848(97)00053-4
  7. Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007;5:296-304. https://doi.org/10.1111/j.1538-7836.2007.02328.x
  8. Perrier A, Roy PM, Aujesky D, Chagnon I, Howarth N, Gourdier AL, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004;116: 291-9. https://doi.org/10.1016/j.amjmed.2003.09.041
  9. Sidelmann JJ, Gram J, Larsen A, Overgaard K, Jespersen J. Analytical and clinical validation of a new point-of-care testing system for determination of D-Dimer in human blood. Thromb Res 2010;126:524-30. https://doi.org/10.1016/j.thromres.2010.08.012
  10. Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, et al. A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med 1998;243:15-23. https://doi.org/10.1046/j.1365-2796.1998.00249.x
  11. Bland JM and Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
  12. Brotman DJ, Segal JB, Jani JT, Petty BG, Kickler TS. Limitations of Ddimer testing in unselected inpatients with suspected venous thromboembolism. Am J Med 2003;114:276-82. https://doi.org/10.1016/S0002-9343(02)01520-6
  13. Geersing GJ, Janssen KJ, Oudega R, Bax L, Hoes AW, Reitsma JB, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ 2009;339:b2990. https://doi.org/10.1136/bmj.b2990

Cited by

  1. Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents vol.12, pp.None, 2013, https://doi.org/10.1186/s12959-014-0028-7
  2. Comments on Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study vol.34, pp.1, 2013, https://doi.org/10.3343/alm.2014.34.1.64
  3. Response to the Comments on 'Point of Care D-Dimer Testing in the Emergency Department-A Bioequivalence Study' and Erratum to the Results vol.34, pp.1, 2013, https://doi.org/10.3343/alm.2014.34.1.66
  4. Fluorescence Immunoassay of Human D‐dimer in Whole Blood vol.28, pp.4, 2013, https://doi.org/10.1002/jcla.21683
  5. Point-of-care testing in the overcrowded emergency department – can it make a difference? vol.18, pp.6, 2013, https://doi.org/10.1186/s13054-014-0692-9
  6. Platelet and Other Hemostatic Characteristics in Patients With Chronic Urticaria vol.66, pp.4, 2015, https://doi.org/10.1177/0003319714552693
  7. D-dimer testing for safe exclusion and risk stratification in patients with acute pulmonary embolism in primary care vol.20, pp.7, 2013, https://doi.org/10.4103/1735-1995.166217
  8. Widely Used Types and Clinical Applications of D-Dimer Assay vol.47, pp.2, 2013, https://doi.org/10.1093/labmed/lmw001
  9. MnFe2O4nanoclusters as labels for the quantitative detection of D-dimer in a lateral-flow immunochromatographic assay vol.66, pp.3, 2019, https://doi.org/10.1002/jccs.201800134
  10. Current Status of Clinical Application of Point-of-Care Testing vol.145, pp.2, 2013, https://doi.org/10.5858/arpa.2020-0112-ra